Related Experiment Videos

[Variations of plasma Willebrand factor and fibrinogen in coronary pathology]

M L Wiesel1, J M Mossard, L Grunebaum

  • 1Service d'hémostase et de thrombose, INSERM U 311, centre régional de transfusion sanguine, Strasbourg, France.

Insights

Plasma von Willebrand factor is a reliable marker for detecting transmural myocardial infarction. Elevated levels indicate a prethrombotic state, aiding in early diagnosis of heart attacks.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarker Discovery

Context:

  • Precordial chest pain is a common symptom requiring accurate diagnosis.
  • Identifying reliable markers for prethrombotic states is crucial for patient management.
  • Distinguishing between different causes of chest pain, including myocardial infarction and angina, is essential.

Purpose:

  • To identify a reliable and easily measurable marker for prethrombotic states.
  • To evaluate plasma levels of fibrinogen, von Willebrand factor, cholesterol, triglycerides, white blood cells, and platelets in patients with chest pain.
  • To correlate these markers with specific diagnoses, particularly transmural myocardial infarction.

Summary:

  • Studied 200 patients under 60 with chest pain, categorizing them into transmural myocardial infarction, non-Q wave infarction, unstable angina, and atypical chest pain groups.
  • Measured fibrinogen, von Willebrand factor (vWF), cholesterol, triglycerides, white blood cells, and platelets.
  • Found significant correlations between transmural myocardial infarction and elevated fibrinogen, vWF, and white blood cells. vWF levels peaked on day five post-infarction.

Impact:

  • Plasma von Willebrand factor emerges as a potential reliable biomarker for diagnosing transmural myocardial infarction.
  • This finding aids in the acute phase or within two weeks following a thrombotic cardiac event.
  • Suggests vWF's utility in improving diagnostic accuracy and patient outcomes for acute coronary syndromes.

Related Concept Videos